title: A report from the Conference on Retroviruses and Opportunistic Infections (CROI) 2015 (February 23-26--Seattle, Washington, USA).
abstract: The largest conference on HIV and AIDS, the annual Conference on Retroviruses and Opportunistic Infections (CROI) also encompasses opportunistic and other important pathogens, notably in 2015 hepatitis C virus and the Ebola virus. This year's conference involved 4 days of discussions on highly relevant basic, translational and clinical research and developments in the ongoing battle against these infections.
authors: Thomson Reuters, Barcelona, Spain. xavier.rabasseda@thomsonreuters.com.
authors: X
authors: X
authors: Rabasseda
mesh_terms: D016915:AIDS Vaccines; D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000821:virology; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D055808:Drug Discovery; D015316:Genetic Therapy; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans
chemical_list: D016915:AIDS Vaccines; D019380:Anti-HIV Agents
keywords: AIDS; Antiretroviral therapies; Ebola virus; HIV; Hepatitis C virus